BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PhotoThera, Inc. Announces New President And Chief Executive Officer


4/7/2006 10:38:07 AM

CARLSBAD, Calif., April 6 /PRNewswire/ -- PhotoThera Inc. today announced it has hired medical device veteran Thomas Wilder as President and Chief Executive Officer. Wilder will commence his new role on April 17th 2006. Jackson Streeter M.D., the Company's Founder and current Chief Executive Officer, will continue to serve an active role as the Company's Chief Scientific Officer and Chairman. "Tom brings to PhotoThera a broad array of device experience that will prove valuable as we continue to develop and seek regulatory approval for our proprietary ischemic stroke technology. We are delighted to have Tom on board," Streeter said.

Wilder served most recently as the President of ev3's Neurovascular Division. From October 2002 to January 2006, he served as President and Chief Executive Officer of MicroTherapeutics Inc. (MTI), a publicly-held medical device company focused on neurovascular technologies. MTI was a majority-owned subsidiary of ev3 that was merged fully into ev3 in January 2006.

From 1991 to 2002, Wilder served at Medtronic Inc., most recently as Vice President and General Manager of its endovascular stent grafts division. During his tenure at Medtronic, he also held a variety of finance, business development, and operations positions at U.S. and international locations, including Hong Kong, Belgium and The Netherlands. Wilder earned a Bachelor of Arts in Economics from Stanford University and a Masters in Management from Northwestern University's Kellogg Graduate School of Management.

"I look forward to working with Dr. Streeter, the PhotoThera team, as well as with our clinical investigators, to develop this important therapy option for stroke patients," said Wilder.

About PhotoThera Inc.

PhotoThera Inc. develops innovative new technology using infrared laser energy for the treatment of ischemic stroke.

Source: PhotoThera Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES